SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-071508
Filing Date
2017-12-04
Accepted
2017-12-04 07:30:30
Documents
4
Period of Report
2017-12-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-27866_18k.htm 8-K 22448
2 EX-99.1 a17-27866_1ex99d1.htm EX-99.1 28053
3 GRAPHIC g278661mmi001.jpg GRAPHIC 5185
4 GRAPHIC g278661mmi002.jpg GRAPHIC 47623
  Complete submission text file 0001104659-17-071508.txt   124737
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 171235579
SIC: 2834 Pharmaceutical Preparations